941 related articles for article (PubMed ID: 29168933)
1. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer.
Nagasaka M; Gadgeel SM
Expert Rev Anticancer Ther; 2018 Jan; 18(1):63-70. PubMed ID: 29168933
[TBL] [Abstract][Full Text] [Related]
2. Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer.
Gadgeel SM
Am Soc Clin Oncol Educ Book; 2017; 37():630-639. PubMed ID: 28561669
[TBL] [Abstract][Full Text] [Related]
3. Systemic and targeted therapies for early-stage lung cancer.
Byron E; Pinder-Schenck M
Cancer Control; 2014 Jan; 21(1):21-31. PubMed ID: 24357738
[TBL] [Abstract][Full Text] [Related]
4. The emerging perioperative treatment paradigm for non-small cell lung cancer: a narrative review.
Christopoulos P
Chin Clin Oncol; 2024 Feb; 13(1):12. PubMed ID: 38372058
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?
Buffoni L; Vavalà T; Novello S
Curr Treat Options Oncol; 2016 Oct; 17(10):54. PubMed ID: 27523606
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant therapy for resectable early non-small cell lung cancer: A protocol for a systematic review and meta-analysis.
Chai T; Zhang P; Lin Y; Zhang Z; Lin W; Kang M; Lin J
Medicine (Baltimore); 2019 Jul; 98(30):e16468. PubMed ID: 31348250
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer.
Spaans JN; Goss GD
Curr Opin Oncol; 2015 Mar; 27(2):102-7. PubMed ID: 25611026
[TBL] [Abstract][Full Text] [Related]
9. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
10. Resectable non-small cell lung cancer Adjuvant chemotherapy: slightly longer survival.
Prescrire Int; 2016 Dec; 25(177):299-301. PubMed ID: 30758927
[TBL] [Abstract][Full Text] [Related]
11. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
Alden RS; Mandrekar SJ; Oxnard GR
Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy in stage III NSCLC.
Allen J; Jahanzeb M
J Natl Compr Canc Netw; 2008 Mar; 6(3):285-93. PubMed ID: 18377847
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
Heon S; Johnson BE
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
[TBL] [Abstract][Full Text] [Related]
15. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.
Horn L; Sandler AB; Putnam JB; Johnson DH
J Thorac Oncol; 2007 May; 2(5):377-83. PubMed ID: 17473651
[TBL] [Abstract][Full Text] [Related]
16. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
17. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
18. [Perioperative therapies in surgical non N2 non-small cell lung cancer].
Ruppert AM; Lavolé A; Assouad J; Cadranel J; Wislez M
Bull Cancer; 2017 Jan; 104(1):79-85. PubMed ID: 27912893
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
Bradbury P; Sivajohanathan D; Chan A; Kulkarni S; Ung Y; Ellis PM
Clin Lung Cancer; 2017 May; 18(3):259-273.e8. PubMed ID: 28162945
[TBL] [Abstract][Full Text] [Related]
20. Role of chemotherapy in stages I to III non-small cell lung cancer.
Strauss GM
Chest; 1999 Dec; 116(6 Suppl):509S-516S. PubMed ID: 10619521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]